29th Apr 2020 18:19
(Alliance News) - Biotechnology company ValiRx PLC on Wednesday confirmed joint venture talks for its non-core intellectual property, GeneICE, TRAC and BioFit.
Shares in the company closed 25% higher at 7.49 pence each in London.
"The company confirms that it is in talks with a third-party in relation to a joint venture. However, there is no certainty the talks will conclude in a successful manner, nor that in the event that the Joint Venture is agreed, that the terms will be favourable to the company," ValiRx said in a statement.
By Tapan Panchal; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ValiRx